Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to 5-Fluorouracil
Related studies linked through entity extraction aliases.
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin
- Status
- UNKNOWN
- Phase
- PHASE3
Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN
- Status
- COMPLETED
- Phase
- PHASE2
Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2